Scotts Miracle-Gro (SMG) Common Equity (2009 - 2026)

Scotts Miracle-Gro has disclosed Common Equity across 18 years of filings, most recently posting -$208.7 million for Q2 2026.

• In Q2 2026, Common Equity fell 22.12% year-over-year to -$208.7 million; the TTM figure through Jun 2026 stood at -$208.7 million (down 22.12% YoY), while the FY2025 annual figure was -$357.5 million, up 8.47% from the prior year.
• Common Equity came in at -$208.7 million for Q2 2026 at Scotts Miracle-Gro, up from -$286.5 million in the prior quarter.
• In the past five years, Common Equity ranged from a high of $975.0 million in Q2 2022 to a low of -$500.6 million in Q4 2025.
• Average Common Equity over 5 years is -$54.2 million, with a median of -$208.7 million recorded in 2026.
• Year-over-year, Common Equity grew 22.47% in 2022 and plunged 747.73% in 2023.
• Over 5 years, Common Equity stood at $59.5 million in 2022, then sank by 747.73% to -$385.4 million in 2023, then decreased by 24.42% to -$479.5 million in 2024, then slipped by 4.4% to -$500.6 million in 2025, then soared by 58.31% to -$208.7 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$208.7 million in Q2 2026, -$286.5 million in Q1 2026, and -$500.6 million in Q4 2025.